A Study to Determine if RADIESSE® Dilute Treatment in Décolleté of Adult Women Affects Radiographic Imaging Assessments

Running, not enrolling · Not applicable

Conditions studied: Décolleté Wrinkles

In brief

The primary purpose of this study is to determine if treatment with Radiesse dilute in the décolleté interferes with radiographic imaging of the breast tissue.

Key facts

Study ID

NCT07086248

Run by

Merz North America, Inc.

People needed

30

Starts

2025-07-22

Expected to finish

2026-11-01

Last updated by the study team

2026-05-08

Who can join

Age: 40 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Participants seeking improvement of moderate to severe décolleté wrinkles.
• Participant is willing to undergo up to three bilateral mammograms and up to four bilateral ultrasound procedures.

You may not qualify if…

• Any pre-existing serious disease or disorder of the breast tissue that may confound interpretation of radiographic and/or ultrasound imaging (example., participants with a history of breast cancer or an immediate family history of breast cancer [that is., mother, sister, and/or daughter], pathogenic or likely pathogenic breast cancer (BRCA) gene variant, calcifications and/or microcalcifications detected on previous mammography [up to three years prior to study start, if available]).
• Present uncontrolled malignant disease.
• Any condition that would caution against receiving additional radiation exposure in the breasts.
• Any previous surgery, including plastic surgery or permanent surgical implant, or previous non-surgical treatment in the planned in the treatment area and in the breasts.

Where it is running

• Merz Investigative Site — Alpharetta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.